Cost-utility analysis of long-acting cabotegravir plus rilpivirine for the treatment of HIV infection in the United Kingdom

被引：0
|
作者：
Parker, B. [1 ]
Chounta, V. [2 ]
Gait, C. [3 ]
Hayward, O. [4 ]
Hunjan, M. [3 ]
Schroeder, M. [2 ]
Jacob, I. [1 ]
Van de Velde, N. [2 ]
机构：
[1] Hlth Econ & Outcomes Res Ltd, Hlth Econ, Cardiff, Wales
[2] ViiV Healthcare, Global Hlth Outcomes, London, England
[3] GSK, Hlth Outcomes, London, England
[4] Hlth Econ & Outcomes Res Ltd, Med Writing, Cardiff, Wales
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P030
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [21] Acute Hepatitis B Infection After a Switch to Long-Acting Cabotegravir and Rilpivirine
    Pintado, Claire
    Delaugerre, Constance
    Molina, Jean-Michel
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (09):
  • [22] Cabotegravir plus rilpivirine long-acting as HIV-1 maintenance therapy: ATLAS Week 96 results
    Swindells, S.
    Lutz, T.
    Van Zyl, L.
    Porteiro, N.
    Benn, P.
    Huang, J.
    Harrington, C.
    Hove, K.
    Ford, S.
    Talarico, C.
    Chounta, V.
    Crauwels, H.
    Van Solingen-Ristea, R.
    Vanveggel, S.
    Margolis, D.
    Smith, K.
    Vandermeulen, K.
    Spreen, W.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 19 - 21
  • [23] Cabotegravir plus rilpivirine long-acting as HIV-1 maintenance therapy: ATLAS week 96 results
    Swindells, Susan
    Lutz, Thomas
    Van Zyl, Lelanie
    Porteiro, Norma
    Benn, Paul
    Huang, Jenny O.
    Harrington, Conn M.
    Hove, Kai
    Ford, Susan L.
    Talarico, Christine L.
    Chounta, Vasiliki
    Crauwels, Herta
    Van Solingen-Ristea, Rodica
    Vanveggel, Simon
    Margolis, David A.
    Smith, Kimberly Y.
    Vandermeulen, Kati
    Spreen, William R.
    Baum, Alexander
    INFECTION, 2021, 49 (SUPPL 1) : S7 - S8
  • [24] Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals
    Cossu, Maria Vittoria
    Cattaneo, Dario
    Moschese, Davide
    Giacomelli, Andrea
    Soloperto, Sara
    D'Avolio, Antonio
    Antinori, Spinello
    Gori, Andrea
    Rizzardini, Giuliano
    Gervasoni, Cristina
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (05) : 1126 - 1132
  • [25] Use of long-acting cabotegravir plus rilpivirine during hemodialysis and solid organ transplantation
    Rezzonico, Leonardo F.
    Baldassari, Luca
    Peracchi, Francesco
    Merli, Marco
    Puoti, Massimo
    Rossotti, Roberto
    AIDS, 2023, 37 (09) : 1491 - 1493
  • [26] Efficacy, safety and implementation outcomes of Cabotegravir plus Rilpivirine long-acting by country in the Cabotegravir and rilpivirine implementation study in European locations (CARISEL)
    Jonsson-Oldenbuettel, C.
    Ghosn, J.
    Sierra, J. Olalla
    van der Valk, M.
    Lutz, T.
    Belkhir, L.
    van Welzen, B. J.
    Hove, K.
    Ait-Khaled, M.
    DeMoor, R.
    Bontempo, G.
    Latham, C. L.
    Ngenzi, B.
    Okoli, C.
    Gutner, C. A.
    Iyer, S.
    Gill, M.
    Czarnogorski, M.
    D'Amico, R.
    van Wyk, J.
    HIV MEDICINE, 2023, 24 : 193 - 195
  • [27] Real world use of long-acting cabotegravir and rilpivirine in a HIV centre in Hong Kong
    Chan, M. C. J.
    Chik, S. H. T.
    Lamb, S. S.
    Choi, Y. C. C.
    Lau, W. T. A.
    Leung, C. S. E.
    To, P. Y. L.
    Lau, P. L. D.
    Tsang, T. Y. O.
    HIV MEDICINE, 2023, 24 : 155 - 156
  • [28] Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirine
    Alagaratnam, Jasmini
    Kelly, Niall
    Dustan, Simon
    Naous, Nadia
    Nwanbila, Modest
    Byrne, Ruth
    Girometti, Nicolo
    Asboe, David
    Taylor, Graham P.
    Boffito, Marta
    AIDS, 2025, 39 (01) : 95 - 98
  • [29] Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis
    Cutrell, Amy G.
    Schapiro, Jonathan M.
    Perno, Carlo F.
    Kuritzkes, Daniel R.
    Quercia, Romina
    Patel, Parul
    Polli, Joseph W.
    Dorey, David
    Wang, Yongwei
    Wu, Sterling
    Van Eygen, Veerle
    Crauwels, Herta
    Ford, Susan L.
    Baker, Mark
    Talarico, Christine L.
    St Clair, Marty
    Jeffrey, Jerry
    White, C. Thomas
    Vanveggel, Simon
    Vandermeulen, Kati
    Margolis, David A.
    Aboud, Michael
    Spreen, William R.
    van Lunzen, Jan
    AIDS, 2021, 35 (09) : 1333 - 1342
  • [30] Acute Hepatitis B Infection in a Patient With Confirmed Immunity on Long-Acting Cabotegravir/Rilpivirine
    Boateng, William K. B.
    Carlin, Neil
    Spira, Etan
    Szabela, Maria E.
    Ezeh, Kosisochukwu J.
    ACG CASE REPORTS JOURNAL, 2025, 12 (01)
12345